The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01598337

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Prince Sultan Cardiac Center, Adult Cardiology Department. (from the registry)
Registry
  • NCT NCT01598337
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Saudi Arabia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01598337. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
Intervention (Drug)
Aspirin
Intervention (Drug)
Tirofiban
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Prasugrel
Lead sponsor
Prince Sultan Cardiac Center, Adult Cardiology Department. (class: other)

Record details

Record id
cardio:ct-nct01598337
Content hash
0d7e365954395e7acd0e2c5879d1013c1de3f69bb38bc75185f6d4ada370c812